- (PLX AI) – Novozymes Q1 sales DKK 4,371 million vs. estimate DKK 4,185 million.
- • Q1 EBIT DKK 1,142 million vs. estimate DKK 1,100 million
- • Q1 EBIT margin 26.1%
- • Q1 net income DKK 839 million
- • Outlook FY organic sales growth raised to 4-8% from 3-7% previously
- • Outlook FY EBIT margin unchanged at 16-17%
- • Says good momentum on pricing initiatives with an overall neutral impact in Q1